Gregory Beatty is an Oncology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 290 publications with 16,130 citations (h-index 49); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Civic Center Boulevard
Philadelphia, PA 191045127
Telephone
215-615-5858Registry record last updated 22 Aug 2019.
Clinical trials
- Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- EMD Serono Research & Development Institute, Inc.Program year20251 payment
- EMD Serono Research & Development Institute, Inc.Program year20241 payment
- Legend Biotech USA Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Targeting the liver for immunotherapy in pancreatic cancer
University of Pennsylvania
FY2026$347,344R01CA197916
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
Science Immunology
2023 - Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Annual Review of Pathology Mechanisms of Disease
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”